Description
8-Week Total Recovery System
A complete nine-vial research protocol pairing three complementary compounds — tissue-repair peptides, a dual-pathway growth-hormone secretagogue, and the cellular coenzyme NAD+ — for research spanning structural, hormonal and cellular pathways.
§ 01 — The System
Three compounds, three research pathways.
| Tissue-repair research spans three areas: structural repair signaling, growth-hormone signaling, and cellular energy metabolism. Addressing only one of those leaves the process under-resourced. This system supplies all three, together, across an eight-week arc.
The Wolverine Blend drives structural repair. The CJC-1295 / Ipamorelin stack amplifies growth-hormone and IGF-1 signaling. NAD+ fuels the energy-intensive cellular machinery behind both. Every vial is research-grade, HPLC-verified above ninety-nine percent purity, and lot-verified for reproducible protocol work. |
Tissue repair is energy-expensive and hormone-dependent. Giving repair peptides without the cellular fuel and anabolic signaling to support them is like framing a house with no power to the site.
|
§ 02 — The Three Pillars
Three compounds, nine vials — each covering what the others cannot.
×3 · Wolverine Blend
Structural Repair10 mg BPC-157 + 10 mg TB-500 BPC-157 is studied for localized repair signaling — angiogenesis, growth-factor signaling, and tendon, ligament and gut tissue models. TB-500 (thymosin β-4 fragment) works systemically, mobilizing repair cells and remodeling actin. One builds the repair infrastructure; the other moves the crew into position. |
×3 · CJC-1295 / Ipamorelin
Growth Signal5 mg CJC-1295 + 5 mg Ipamorelin A GHRH analog paired with a selective ghrelin mimetic, stimulating growth hormone through two pathways at once for a larger, cleaner pulse. The resulting GH → IGF-1 signaling is studied in relation to protein synthesis, collagen turnover and connective-tissue repair. |
×3 · NAD+
Cellular Fuel500 mg per vial The coenzyme at the center of mitochondrial ATP production, DNA repair, and sirtuin signaling. NAD+ is studied as a coenzyme in the energy-dependent processes involved in repair. |
§ 03 — Why All Three
A single cascade — four steps, three compounds, one outcome.
i
Repair the StructureBPC-157 and TB-500 lay down new blood vessels and migrate repair cells into damaged tendon, ligament, muscle, and soft tissue. |
ii
Signal the GrowthThe GH/IGF-1 pulse from CJC-1295 / Ipamorelin drives protein synthesis and collagen deposition — turning repair signaling into actual tissue. |
iii
Fuel the ProcessNAD+ sustains the mitochondrial energy and DNA-repair capacity that every step above depends on — the power behind the machinery. |
iv
Compound the EffectTogether, the three compounds allow structural, hormonal and cellular pathways to be studied in parallel. |
✦
On Layering
The rationale for a system over a single compound is coverage. Repair peptides, GH/IGF-1 signaling and NAD+ represent three distinct research pathways. Addressed together, each amplifies the return on the others; addressed alone, each runs into the ceiling the other two would have lifted.
§ 04 — Research Applications
Primary subjects of investigation — strictly laboratory use.
A.01
Soft-Tissue RepairStudies of tendon, ligament, muscle, and gut healing under combined local and systemic repair-peptide signaling. |
A.02
Recovery & SleepResearch into GH/IGF-1-mediated recovery, sleep architecture, and overnight tissue restoration. |
A.03
Connective TissueInvestigating collagen synthesis, joint and tendon integrity, and the anabolic support of structural remodeling. |
A.04
Cellular ResilienceExamining NAD+-dependent mitochondrial energy and DNA-repair capacity as the metabolic floor for recovery. |
§ 05 — Scientific References
Peer-reviewed literature supporting the components of this system.
| i. |
BPC-157 & Tendon RepairPreclinical research reporting that BPC-157 accelerates tendon-to-bone and ligament healing through angiogenesis and growth-factor pathway activation — the localized half of the Wolverine repair signal. |
|
| ii. |
Thymosin β-4 & Cell MigrationFoundational studies characterizing the actin-binding domain of thymosin β-4 (TB-500) and its role in cell migration, angiogenesis, and anti-fibrotic tissue organization — the systemic half of the repair response. |
|
| iii. |
GHRH + Ghrelin Pathway SynergyResearch demonstrating that co-stimulating the GHRH and ghrelin receptors yields a greater growth-hormone response than either pathway alone — the basis for pairing CJC-1295 with ipamorelin. |
|
| iv. |
Age-Related Decline of NAD+A foundational study showing tissue NAD+ levels fall substantially with age and metabolic demand, with measurable consequences for mitochondrial function and repair capacity — the rationale for including NAD+ in this research set. |
§ 06 — Kit Contents & Specifications
Certificate of analysis available upon request for each compound.
| System | 8-Week Total Recovery System · 9 vials |
| Wolverine Blend ×3 | 20 mg each · 10 mg BPC-157 + 10 mg TB-500 |
| CJC-1295 / Ipamorelin ×3 | 10 mg each · 5 mg CJC-1295 (no DAC) + 5 mg Ipamorelin |
| NAD+ ×3 | 500 mg each · β-Nicotinamide Adenine Dinucleotide |
| Format | Lyophilized Powder (Freeze-dried) |
| Purity | > 99% (HPLC Verified) |
| Storage — Unreconstituted | Store at −20°C · Protect from light |
| Storage — Reconstituted | Refrigerate at 2–8°C · Use within ~28 days · Do not freeze |
| Reconstitution | Bacteriostatic Water |
Research Use OnlyAll products listed are intended exclusively for laboratory research and development purposes. They are not intended for human consumption, diagnostic, or therapeutic use. Customers must be at least 21 years of age to purchase.
Reviews
There are no reviews yet.